Dr. Ashok Srivastava, MD, Ph.D., MBA
New York City Metropolitan Area
17K followers
500+ connections
About
Make a significant difference in solid tumors and hematologic malignancy space…
Activity
-
My visit to Indian Institute of Science (IISc) Bangalore has been an extraordinary experience, one that has left a lasting impression on me. From…
My visit to Indian Institute of Science (IISc) Bangalore has been an extraordinary experience, one that has left a lasting impression on me. From…
Liked by Dr. Ashok Srivastava, MD, Ph.D., MBA
-
Not a football fan? Check out the NRG Oncology Podcast instead, created to allow everyone to listen to topics regarding cancer care, trial barriers &…
Not a football fan? Check out the NRG Oncology Podcast instead, created to allow everyone to listen to topics regarding cancer care, trial barriers &…
Liked by Dr. Ashok Srivastava, MD, Ph.D., MBA
-
Looking forward to sharing my thoughts in this webinar tomorrow.
Looking forward to sharing my thoughts in this webinar tomorrow.
Liked by Dr. Ashok Srivastava, MD, Ph.D., MBA
Experience
-
Trans Atlantic Therapeutics- Oncology/Hematology
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
-
- Present
-
-
Activities and Societies: Nagasaki Cancer Hospital
-
-
-
Activities and Societies: Medical Oncology and Hematology. Pharmaceutical Business Management • School of Medicine Nagasaki University School of Medicine, Nagasaki, Japan • Rutgers University Business School of Management, New Jersey, USA • Czechoslovak Academy of Medical Sciences, Prague, Czechoslovakia • All India Institute of Medical Sciences, New Delhi, India
Board Certification in Medical Affairs
Breast cancer, Lung cancer, Supportive care,
Board member of cancer drug development
Board Member of Calidi Biotherapeutics
Board Member Carcinotech Ltd, UK -
Activities and Societies: Onco-virology
-
-
-
-
-
-
-
•American Association of Clinical Oncology
• Head and Neck cancer Foundation
• Breast Cancer Foundation
• International Society of Lung Cancer
• American Society of Hematology
• Foundation of Chemotherapy
• Royal College of Pathologists, UK
• Indo American Cancer Association, US based Oncologists of Indian Heritage. -
Licenses & Certifications
-
Private Aircraft Pilot- Licensed
Advanced Aviation Group, Frederick, MD
-
ESMO: European Society for Medical Oncology; European Certification in Medical Oncology
ESMO - European Society for Medical Oncology
Issued -
Awards: United Nation Fellow Award Best Oncologist of USA, 2017 Best Oncologist of USA, 2011 Best Clinical Fellow Award: Walter Reed Army Institute of Research and Walter Reed Army Medical Center, Washington DC , USA
Medical Affairs Competency
-
Clinical Trials in Oncology
The Alliance for Clinical Trials in Oncology
Credential ID A network of oncologists, surgeons, and radiation oncologists. -
Japanese association of pharmaceutical medicine (日本製薬医学会)
Medical Affairs Competency
Publications
-
CAR-T Cell Therapy for Relapsed/Refractory Hematologic Malignancies Adverse Events in Risks and Maximizing Safety: Ashok Srivastava, MD, Ph.D. and Pallavi Dhillon, PharmD, Ph.D.;
In Press
-
A Phase 1b, to Investigate the Safety, Pharmacokinetics and Antitumor Activities of RAF Dimer Inhibitor Lifirafenib in Combination with MEK inhibitor Mirdametinib in Patients with Advanced or Refractory Solid Tumors
ASCO
-
Integrated Results of Two Multicenter, Randomized, Placebo Controlled, Double Blind, Phase 3 Trials of Single-Dose Intravesical Apaziquone Immediately Following Resection in Patients with Non-Muscle Invasive Bladder Cancer
AUA-2016, San Diego
-
CAR-T Cell Therapy for Relapsed/Refractory Hematologic Malignancies: Ashok Srivastava, MD, Ph.D., MBA....In Press 2024
-
Patents
-
Inactivated Japanese Encephalitis Vaccine
US Patent No.: US 6,309,650 B1
Attenuated Japanese Encephalitis Virus Adapted to Vero Cell and A Japanese Encephalitis Vaccine-
To prevent Japanese encephalitis disease!!! -
Recombinant Dengue Virus Vaccine
US Patent Number: 6,117,640
A recombinant protein encompassing a C-terminal protion from the structural envelope glycoprotein and an N-terminal portion from non-structural protein one of dengue type 2 virus was expressed in Escherichia coli as a fusion protein with Staphylococcal protein A. The recombinant protein was found to provide protection against lethal challenge with dengue 2 virus.
Honors & Awards
-
Licensed Pilot
-
-
Award
-
• United Nation Fellow Award
• Best Oncologist of USA, 2017
• Best Oncologist of USA, 2011
• Clinical Fellow award, Walter Reed Medical Center, Washington DC, USA
• Best Clinical Fellow Award: Walter Reed Army Institute of Research, Washington DC, USA
• Clinical Fellowship of Ministry of Health, Japan
• Fellow, National Academy of Sciences, Washington, DC, USA
Languages
-
Japanese
Full professional proficiency
More activity by Dr. Ashok
-
Wishing you all a joyful and prosperous Ganesh Chaturthi! May Lord Ganesha bless you with wisdom, strength, and remove all obstacles from your path…
Wishing you all a joyful and prosperous Ganesh Chaturthi! May Lord Ganesha bless you with wisdom, strength, and remove all obstacles from your path…
Liked by Dr. Ashok Srivastava, MD, Ph.D., MBA
-
“I am impressed by EyePoint’s significant potential in developing safe and effective treatments for important unmet needs in retinal…
“I am impressed by EyePoint’s significant potential in developing safe and effective treatments for important unmet needs in retinal…
Liked by Dr. Ashok Srivastava, MD, Ph.D., MBA
-
Returning to the Rakuten Technology Conference each year fills me with joy! At Rakuten, our passion for innovation runs deep and we know that true…
Returning to the Rakuten Technology Conference each year fills me with joy! At Rakuten, our passion for innovation runs deep and we know that true…
Liked by Dr. Ashok Srivastava, MD, Ph.D., MBA
-
A heartfelt thank you to #JamiaHamdardUniversity, #SchoolofChemicalandLifeSciences, for inviting me as the Guest of Honor at the Induction Program…
A heartfelt thank you to #JamiaHamdardUniversity, #SchoolofChemicalandLifeSciences, for inviting me as the Guest of Honor at the Induction Program…
Liked by Dr. Ashok Srivastava, MD, Ph.D., MBA
-
Introducing Western India’s First EDGE Radiosurgery System with HyperArc Technology at Nanavati Max Super Speciality Hospital. This cut- edging…
Introducing Western India’s First EDGE Radiosurgery System with HyperArc Technology at Nanavati Max Super Speciality Hospital. This cut- edging…
Liked by Dr. Ashok Srivastava, MD, Ph.D., MBA
-
Cambridge-based biotech Mestag Therapeutics has shared in a £12 million Innovate UK grant to advance nextgen immunotherapies for cancer. The company…
Cambridge-based biotech Mestag Therapeutics has shared in a £12 million Innovate UK grant to advance nextgen immunotherapies for cancer. The company…
Liked by Dr. Ashok Srivastava, MD, Ph.D., MBA
-
Love this infographic on my TEDxSanDiego talk from Liquid Sketch Studios! It’s so cool to see my message captured in a different format—especially…
Love this infographic on my TEDxSanDiego talk from Liquid Sketch Studios! It’s so cool to see my message captured in a different format—especially…
Liked by Dr. Ashok Srivastava, MD, Ph.D., MBA
-
The FDA has accepted the Biologics License Application (BLA) for our TROP2 directed antibody drug conjugate (#ADC) for the treatment of certain adult…
The FDA has accepted the Biologics License Application (BLA) for our TROP2 directed antibody drug conjugate (#ADC) for the treatment of certain adult…
Liked by Dr. Ashok Srivastava, MD, Ph.D., MBA
-
Engineering cellular therapies to enhance therapeutic resistance offers a significant boost to cancer treatment. By making cells resistant to…
Engineering cellular therapies to enhance therapeutic resistance offers a significant boost to cancer treatment. By making cells resistant to…
Liked by Dr. Ashok Srivastava, MD, Ph.D., MBA
-
Attention SoCal Nurses! Join us for the 15th Annual Neuroscience Nursing Symposium! 🎓✨ Dive into the latest in neuroscience with expert speakers…
Attention SoCal Nurses! Join us for the 15th Annual Neuroscience Nursing Symposium! 🎓✨ Dive into the latest in neuroscience with expert speakers…
Liked by Dr. Ashok Srivastava, MD, Ph.D., MBA
-
Get ready to make a difference at the Los Angeles Brain Tumor 5K (BT5K)! 🌟👟 Join us on Saturday, October 26, 2024, at Tongva Park in Santa Monica…
Get ready to make a difference at the Los Angeles Brain Tumor 5K (BT5K)! 🌟👟 Join us on Saturday, October 26, 2024, at Tongva Park in Santa Monica…
Liked by Dr. Ashok Srivastava, MD, Ph.D., MBA
-
🎊 We’re thrilled to announce that Cortechs.ai has received FDA 510(k) clearance for NeuroQuant® 5.0! This update introduces advanced segmentation…
🎊 We’re thrilled to announce that Cortechs.ai has received FDA 510(k) clearance for NeuroQuant® 5.0! This update introduces advanced segmentation…
Liked by Dr. Ashok Srivastava, MD, Ph.D., MBA
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More